Eisai Co., Ltd. (TYO:4523)
3,983.00
+95.00 (2.44%)
Apr 18, 2025, 3:30 PM JST
Eisai Employees
Eisai had 11,067 employees as of March 31, 2024. The number of employees decreased by 9 or -0.08% compared to the previous year.
Employees
11,067
Change (1Y)
-9
Growth (1Y)
-0.08%
Revenue / Employee
71.53M JPY
Profits / Employee
5.31M JPY
Market Cap
1,122.76B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Chugai Pharmaceutical | 7,778 |
Takeda Pharmaceutical Company | 49,281 |
Daiichi Sankyo Company | 18,726 |
HOYA Corporation | 35,702 |
Otsuka Holdings | 35,338 |
Astellas Pharma | 14,754 |
Olympus | 28,838 |
Shionogi & | 4,959 |
Eisai News
- 3 days ago - Biogen/ Eisai win EU approval for Alzheimer’s therapy - Seeking Alpha
- 3 days ago - EU authorizes Eisai-Biogen's drug for treatment of early Alzheimer's disease - Reuters
- 16 days ago - Japanese Stocks Rise With Market Focused on U.S. Trade News - Barron's
- 6 weeks ago - LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer's Treatments| DelveInsight - Benzinga
- 7 weeks ago - EU regulator not updating opinion on Eisai-Biogen's Alzheimer's drug - Reuters
- 7 weeks ago - Eisai: Will Have No Problem Hitting Leqembi Forecasts - Seeking Alpha
- 2 months ago - Q3 2025 Eisai Co Ltd Earnings Presentation Transcript - GuruFocus
- 2 months ago - Eisai projects 42.5B yen global revenue for LEQEMBI in FY2024 amid pathway expansion - Seeking Alpha